Connection

Bryan Toole to Antigens, Neoplasm

This is a "connection" page, showing publications Bryan Toole has written about Antigens, Neoplasm.
Connection Strength

1.516
  1. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res. 2004 Feb 15; 64(4):1229-32.
    View in: PubMed
    Score: 0.217
  2. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem. 2003 Jul 11; 278(28):25285-8.
    View in: PubMed
    Score: 0.206
  3. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol. 2003; 54:371-89.
    View in: PubMed
    Score: 0.201
  4. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol. 2001 Mar; 186(3):371-9.
    View in: PubMed
    Score: 0.177
  5. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res. 2000 Feb 15; 60(4):888-91.
    View in: PubMed
    Score: 0.164
  6. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol. 2004 Mar; 202(3):341-51.
    View in: PubMed
    Score: 0.054
  7. Correlation of emmprin expression in vascular endothelial cells with blood-brain-barrier function: a study using magnetic resonance imaging enhanced by Gd-DTPA and immunohistochemistry in brain tumors. Virchows Arch. 2003 Jun; 442(6):577-84.
    View in: PubMed
    Score: 0.051
  8. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem. 2002 Jun 21; 277(25):22959-65.
    View in: PubMed
    Score: 0.048
  9. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci U S A. 2001 May 22; 98(11):6360-5.
    View in: PubMed
    Score: 0.045
  10. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer. 2000 Oct 01; 88(1):21-7.
    View in: PubMed
    Score: 0.043
  11. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett. 2000 Sep 01; 157(2):177-84.
    View in: PubMed
    Score: 0.043
  12. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer. 2000 Feb 01; 85(3):347-52.
    View in: PubMed
    Score: 0.041
  13. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem. 1999 Dec; 47(12):1575-80.
    View in: PubMed
    Score: 0.041
  14. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 1998 Dec 11; 441(1):88-92.
    View in: PubMed
    Score: 0.038
  15. Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene. 1998 Oct 05; 220(1-2):99-108.
    View in: PubMed
    Score: 0.037
  16. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem. 1997 May; 45(5):703-9.
    View in: PubMed
    Score: 0.034
  17. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem. 1997 Jan 03; 272(1):24-7.
    View in: PubMed
    Score: 0.033
  18. Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol. 1996 Jun; 106(6):1260-5.
    View in: PubMed
    Score: 0.032
  19. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis. 2002; 19(8):697-702.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.